Pay in 4 interest-free payments of $6.76 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
YM155, an anticancer drug candidate in clinical trials, has also been shown to inhibit SARS-CoV-2 PL pro and has potent antiviral activity (half-maximal effective concentration (EC 50 ) of 170 nM) 80
10.3390/cancers11050678 6
Conclusions By virtue to the present findings, the oral intake of L-carnitine during ovulation induction in PCOS women for 6 weeks had no effect on the number and quality of the obtained oocytes and embryos and the clinical pregnancy rate following FET cycles
3 21
PlexusDx doesn't require insurance, membership fees, or prior authorization
Ascendis Pharma A/S granted Novo Nordisk A/S exclusive global rights to its TransCon technology for the development, manufacturing, and commercialisation of Novo Nordisk products aimed at metabolic diseases, including obesity and type 2 diabetes, along with select cardiovascular applications
US$ 24.60
US$ 26.91
US$ 29.51
US$ 26.29
US$ 27.11
US$ 21.87
